mechanism of action
DNA Barcodes Could Streamline Search for New Drugs to Combat Cancer
Posted on by Dr. Francis Collins
A little more than a decade ago, researchers began adapting a familiar commercial concept to genomics: the barcode. Instead of the black, printed stripes of the Universal Product Codes (UPCs) that we see on everything from package deliveries to clothing tags, they used short, unique snippets of DNA to label cells. These biological “barcodes” enable scientists to distinguish one cell type from another, in much the same way that a supermarket scanner recognizes different brands of cereal.
DNA barcoding has already empowered single-cell analysis, including for nerve cells in the brain. Now, in a new NIH-supported study, DNA barcoding helps in the development of a new method that could greatly streamline an increasingly complex and labor-intensive process: screening for drugs to combat cancer.
Share this:
- Click to share on LinkedIn (Opens in new window)
- Click to share on Pinterest (Opens in new window)
- Click to share on Tumblr (Opens in new window)
- Click to share on Reddit (Opens in new window)
- Click to share on Telegram (Opens in new window)
- Click to share on WhatsApp (Opens in new window)
- Click to share on Skype (Opens in new window)
- Click to print (Opens in new window)
Tags: barcoded cancer cell lines, biotechnology, BRD-7880, cancer, cancer cell lines, cancer drugs, DNA barcode, drug discovery, drug screening, genomics, mechanism of action, oncology, Precision Medicine Initiative, PRISM, Profiling Relative Inhibition Simultaneously in Mixtures, single cell analysis